Beurer medical GL 50 evo, Руководство пользователя

Страница: 41 / 44

Beurer GL50 evo 41
Concentration of
tested substances
50-100 mg/dL
(2.8-5.6 mmol/L)
250-350 mg/dL
(13.9-19.4 mmol/L)
L-Dopa 2 mg/dL (0.10 mmol/L) 9.3 mg/dL
(0.52 mmol/L)
7.9%
Maltose 278 mg/dL (7.72 mmol/L) -1.53 mg/dL
(-0.09 mmol/L)
-2.6%
Methyldopa 4 mg/dL (0.19 mmol/L) 7.3 mg/dL
(0.41 mmol/L)
0.9%
Pralidoxime iodide 5 mg/dL (0.14 mmol/L) 1.7 mg/dL
(0.09 mmol/L)
-0.1%
Sodium salicylate 40 mg/dL (2.50 mmol/L) -3.1 mg/dL
(-0.17 mmol/L)
-0.6%
Salicylic acid 60 mg/dL (4.34 mmol/L) -0.1 mg/dL
(-0.01 mmol/L)
7.6%
Tolbutamide 100 mg/dL (3.70 mmol/L) 0.5 mg/dL
(0.03 mmol/L)
-0.8%
Tolazamide 2.5 mg/dL (0.08 mmol/L) -2.3 mg/dL
(-0.13 mmol/L)
1.8%
Triglyceride 800 mg/dL (9.37 mmol/L) -7.50 mg/dL
(-0.42 mmol/L)
-4.0%
Uric acid 16.5 mg/dL (0.98 mmol/L) 6.6 mg/dL
(0.37 mmol/L)
1.8%
Xylose
9.5 mg/dL (0.63 mmol/L) 5.6 mg/dL
(0.31 mmol/L)
6.6%
12 w
arranty
/
service
Beurer GmbH, Söflinger Straße 218, 89077 Ulm, Germany (hereinafter referred to as “Beurer”) provides
a warranty for this product, subject to the requirements below and to the extent described as follows.
The warranty conditions below shall not affect the seller’s statutory warranty obligations which
ensue from the sales agreement with the buyer.
The warranty shall apply without prejudice to any mandatory statutory provisions on liability.
Blood glucose
value
Influence